Trial
NCT02951117
A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
AbbVie
Collaborators
—
Condition
Multiple Myeloma
Intervention
Venetoclax
Why stopped
No participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-05